Clinical Trials in Périgueux, France
17 recruiting
Showing 1–17 of 17 trials
Recruiting
Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Refractory Follicular LymphomaFollicular LymphomaRelapsed/Refractory Follicular Lymphoma
Epizyme, Inc.612 enrolled229 locationsNCT04224493
Recruiting
Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France
Diabetes Type 1
mylife Diabetes Care AG125 enrolled20 locationsNCT07048795
Recruiting
REBECCA Real-world Early BrEast CanCer mAnagement
Breast Cancer
AstraZeneca126 enrolled44 locationsNCT06856343
Recruiting
French Prospective Multicentric Study in Real World
Diabetes MellitusDiabetesType 1 Diabetes
Insulet Corporation304 enrolled24 locationsNCT07039942
Recruiting
UroCCR Database: French Research Network for Kidney Cancer -UroCCR
Kidney Cancer
University Hospital, Bordeaux30,000 enrolled58 locationsNCT03293563
Recruiting
Phase 3
Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
Anal Cancer
Federation Francophone de Cancerologie Digestive310 enrolled114 locationsNCT06207981
Recruiting
Phase 2
Study of Lacutamab in Peripheral T-cell Lymphoma
Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837
Recruiting
Phase 3
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome824 enrolled64 locationsNCT06918002
Recruiting
Phase 4
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
Lymphoma, Non-HodgkinStreptococcus PneumoniaeVaccine
Poitiers University Hospital160 enrolled7 locationsNCT04460235
Recruiting
Not Applicable
EkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation
Diabetes Type 1Diabetes Type 2 on InsulinPancreatogenous Diabetes
DiappyMed154 enrolled16 locationsNCT06738849
Recruiting
Not Applicable
Cost-utility of Focal HIFU vs Prostatectomy
Prostate Cancer
University Hospital, Bordeaux346 enrolled20 locationsNCT05710861
Recruiting
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
HIV InfectionsAntiretroviral Agents
University Hospital, Bordeaux7,200 enrolled24 locationsNCT03296202
Recruiting
Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer
Ovarian Cancer
ARCAGY/ GINECO GROUP327 enrolled24 locationsNCT06660147
Recruiting
Phase 3
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
Chronic Myeloid LeukemiaTyrosine Kinase Inhibitors
Poitiers University Hospital140 enrolled20 locationsNCT05753384
Recruiting
Phase 3
Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over
Colonic Adenocarcinoma
Federation Francophone de Cancerologie Digestive774 enrolled140 locationsNCT02355379
Recruiting
Not Applicable
Transplantation After Complete Response In Patients With T-cell Lymphoma
Peripheral T Cell Lymphoma
Hospices Civils de Lyon204 enrolled48 locationsNCT05444712
Recruiting
Phase 2
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B Cell Lymphoma
ImmunoVaccine Technologies, Inc. (IMV Inc.)102 enrolled50 locationsNCT04920617